A Bioequivalence Study of Two Different PEG-rhGH Preparations.

Clinical trial NCT06331026 · COMPLETED

Trial details

NCT number: NCT06331026
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency (PGHD)

Start date: 2024-04-09
Primary completion: 2024-07-15
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.